Han Yefei, Wind-Rotolo Megan, Yang Hung-Chih, Siliciano Janet D, Siliciano Robert F
Department of Medicine, Johns Hopkins University School of Medicine, 879 BRB 733 N. Broadway, Baltimore, Maryland 21205, USA.
Nat Rev Microbiol. 2007 Feb;5(2):95-106. doi: 10.1038/nrmicro1580.
Viral latency is a reversibly non-productive state of infection that allows some viruses to evade host immune responses. As a consequence of its tropism for activated CD4(+) T cells, HIV-1 can establish latent infection in resting memory CD4(+) T cells, which are generated when activated CD4(+) T cells return to a quiescent state. Latent HIV-1 persists as a stably integrated but transcriptionally silent provirus. In this state, the virus is unaffected by immune responses or antiretroviral drugs, and this latent reservoir in resting CD4(+) T cells is a major barrier to curing the infection. Unfortunately, there is no simple assay to measure the number of latently infected cells in a patient, nor is there an entirely representative in vitro model in which to explore the molecular mechanisms of latency. This Review will consider current approaches to the analysis of HIV-1 latency both in vivo and in vitro.
病毒潜伏是一种可逆的非增殖性感染状态,使一些病毒能够逃避宿主免疫反应。由于HIV-1对活化的CD4(+) T细胞具有嗜性,它可在静息记忆CD4(+) T细胞中建立潜伏感染,这些细胞是在活化的CD4(+) T细胞恢复到静止状态时产生的。潜伏的HIV-1以稳定整合但转录沉默的前病毒形式持续存在。在这种状态下,病毒不受免疫反应或抗逆转录病毒药物的影响,静息CD4(+) T细胞中的这种潜伏库是治愈感染的主要障碍。不幸的是,没有简单的检测方法来测量患者体内潜伏感染细胞的数量,也没有完全具有代表性的体外模型来探索潜伏的分子机制。本综述将探讨目前体内和体外分析HIV-1潜伏的方法。